Back

Prognostic significance of cardiopulmonary exercise testing parameters for predicting all-cause mortality in chronic heart failure patients: a cohort study

28 August 2026 (08:15 - 08:45)
Organised by: Logo
Congress Presentation Part of: Predicting prognosis in heart failure Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Panayiotis Iliakis

Hippokration General Hospital, Athens (Greece)

4 More presentations in this session

Presentation thumbnail
Prognostic value of symptom-limited cardiopulmonary exercise testing outcomes on composite clinical outcomes and echocardiographic remodeling in patients with heart failure: a prospective cohort study
Miss C. Wang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Adverse effect of left ventricular hypertrophy in women with heart failure
Doctor A. Kaplan (Ramat Gan, IL)
Abstract Slides
Presentation thumbnail
Subsequent pregnancy in women with prior peripartum cardiomyopathy: the prognostic role of baseline LVEF
Doctor N. Shamsieva (Tashkent, UZ)
Abstract Slides
Presentation thumbnail
Prognostic impact of prolonged QRS duration on cardiovascular outcomes in chronic heart failure without ventricular pacing or cardiac resynchronization therapy: a systematic review and meta-analysis
Doctor G. Caldeira Gaelzer (Curitiba, BR)
Abstract Slides

Access the full session

Session thumbnail
Predicting prognosis in heart failure

The Event

Event poster

ESC Congress 2026

28 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic values of cardiopulmonary exercise testing parameters for different peak respiratory exchange ratios in patients with cardiovascular disease
4 April 2025
thumbnail
Congress Presentation
Predicting mortality in patients with heart failure and obstructive chronic coronary syndrome
21 May 2023
thumbnail
Congress Presentation
Long-term prognostic value of baseline measurements and change over time of 6-minute walk test in patients with heart failure - A secondary analysis from the HF-Wii study
23 May 2023
thumbnail
Congress Presentation
From arterial hypertension to left ventricular hypertrophy and heart failure: role of CPET in heart failure with preserved ejection fraction patients evaluation
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources